National Advertising Division Inquiry Leads to Removal of Glow Fairy Advertisement on Beauty Website

New York, NY – November 21, 2023 – Through its advertising monitoring program, BBB National Programs’ National Advertising Division (NAD) inquired about Glow Fairy advertising on the Beauty and Style Daily website, which included the claim “2023’s ‘5 Best’ Eye Creams on the Market.”

NAD’s inquiry focused on whether the format of the challenged advertising reasonably communicated that the Glow Fairy product recommendations on Beauty and Style Daily were independent editorial endorsements or advertisements. 

Toward the end of the inquiry, the hyperlink connecting the Beauty and Style website and the Glow Fairy website was removed and the site became non-functional.

During its inquiry, NAD found that there was no disclosure that the Beauty and Style Daily site was advertising Glow Fairy products. Yet the top recommended product on its website was a Glow Fairy product and the links to purchase other products led consumers to the Glow Fairy website. Further, the “About us” hyperlink at the bottom of the Beauty and Style webpage directed consumers to the Glow Fairy website. 

NAD noted that consumers should understand when digital publishers have a relationship with a brand they are promoting and when the content they are viewing is advertising. This enables consumers to better distinguish between editorial and advertising content. 

NAD cautioned Glow Fairy to disclose when it is advertising and avoid displaying advertising content as independent editorial endorsements. 

In its advertiser statement, Glow Fairy stated that it “will comply with NAD’s recommendation” and indicated that it “has stepped up efforts to monitor claims made by third-parties in hopes of furthering efforts to prevent misleading claims and maintaining brand integrity.”

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Per NAD/NARB procedures, this release shall not be used for advertising or promotional purposes.

 

Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.

 

 

 

 

Latest Decisions

Decision

In National Advertising Division Challenge Admire Aesthetics Voluntarily Discontinues Claims for Compounded Tirzepatide

New York, NY – January 23, 2025 – In a BBB National Programs’ National Advertising Division challenge brought by Eli Lilly, Admire Aesthetics voluntarily discontinued certain advertising claims for its compounded tirzepatide product.

Read the Decision Summary
Decision

National Advertising Division Finds Certain Claims for Brainiac Applesauce and Gummy Vitamins Supported; Recommends Others be Discontinued or Modified

New York, NY – January 22, 2025 – The National Advertising Division determined that Ingenuity Brands provided a reasonable basis for certain claims for its Brainiac Brain Squeezers Applesauce products and BrainPack Daily Adult Gummy Vitamins, but recommended other claims be discontinued or...

Read the Decision Summary
Decision

National Advertising Division Recommends Procter & Gamble Modify or Discontinue Certain #1 Claims for Tide Free & Gentle

New York, NY – January 17, 2025 – The National Advertising Division recommended that P&G modify the claim “From Tide, the #1 brand used by dermatologists” when used in connection with imagery for Tide Free & Gentle and discontinue the related claim “From Tide, the #1 Trusted Detergent Brand for Sensitive...

Read the Decision Summary
Decision

National Advertising Division Recommends T-Mobile Discontinue “Families Can Save 20% Every Month Versus AT&T and Verizon” Claim

New York, NY – January 16, 2025 – In a Fast-Track SWIFT challenge brought by competitor AT&T, BBB National Programs’ National Advertising Division recommended T-Mobile discontinue its claim for 20% savings on monthly wireless services. 

Read the Decision Summary